Reduced-Dose Rivaroxaban Is Associated with Lower All-Cause Mortality in Older Patients with Nonvalvular Atrial Fibrillation

por Chiou, Wei-Ru, Su, Min-I, Lee, Ying-Hsiang, Lin, Po-Lin, Liu, Cheng-Wei
Publicado 2023

Closed loop stimulation helps with weaning from chronotropic incompetence-related ventilator dependence

por Lin, Shu-I., Liao, Feng-Ching, Chiou, Wei-Ru, Lin, Po-Lin, Kuo, Jen-Yuan, Tsai, Cheng-Ting, Lee, Ying-Hsiang
Publicado 2021

Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction

por Lee, Ying‐Hsiang, Lin, Po‐Lin, Chiou, Wei‐Ru, Huang, Jin‐Long, Lin, Wen‐Yu, Liao, Chia‐Te, Chung, Fa‐Po, Liang, Huai‐Wen, Hsu, Chien‐Yi, Chang, Hung‐Yu
Publicado 2021

The association between ivabradine and adverse cardiovascular events in acute decompensated HFrEF patients

por Liao, Chia‐Te, Huang, Jin‐Long, Liang, Huai‐Wen, Chung, Fa‐Po, Lee, Ying‐Hsiang, Lin, Po‐Lin, Chiou, Wei‐Ru, Lin, Wen‐Yu, Hsu, Chien‐Yi, Chang, Hung‐Yu
Publicado 2021

Utility of PREDICT-HF score in high-risk Asian heart failure patients receiving sacubitril/valsartan

por Hsu, Chien-Yi, Chang, Hung-Yu, Chao, Chieh-Ju, Chiou, Wei-Ru, Lin, Po-Lin, Chung, Fa-Po, Lin, Wen-Yu, Huang, Jin-Long, Liang, Huai-Wen, Liao, Chia-Te, Lee, Ying-Hsiang
Publicado 2022

Clinical impacts of sacubitril/valsartan on patients eligible for cardiac resynchronization therapy

por Huang, Hsin‐Ti, Huang, Jin‐Long, Lin, Po‐Lin, Lee, Ying‐Hsiang, Hsu, Chien‐Yi, Chung, Fa‐Po, Liao, Chia‐Te, Chiou, Wei‐Ru, Lin, Wen‐Yu, Liang, Huai‐Wen, Chang, Hung‐Yu
Publicado 2022

Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation

por Chiou, Wei-Ru, Lin, Po-Lin, Huang, Chun-Che, Chuang, Jen-Yu, Liu, Lawrence Yu-Min, Su, Min-I, Liao, Feng-Ching, Kuo, Jen-Yuan, Tsai, Cheng-Ting, Wu, Yih-Jer, Wang, Kuang-Te, Lee, Ying-Hsiang
Publicado 2022

Author Correction: Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation

por Chiou, Wei-Ru, Lin, Po-Lin, Huang, Chun-Che, Chuang, Jen-Yu, Liu, Lawrence Yu-Min, Su, Min-I, Liao, Feng-Ching, Kuo, Jen-Yuan, Tsai, Cheng-Ting, Wu, Yih-Jer, Wang, Kuang-Te, Lee, Ying-Hsiang
Publicado 2023

Exploratory Evaluation of Rhythm Control by Dronedarone in Combination With Low-Dose Rivaroxaban, Warfarin, Antiplatelet, or None of the Antithrombotic Therapy in High-Risk Patient...

por Lin, Po-Lin, Chiou, Wei-Ru, Su, Min-I, Huang, Chun-Che, Liao, Feng-Ching, Liu, Lawrence Yu-Min, Chuang, Jen-Yu, Chen, Chun-Yen, Tsai, Cheng-Ting, Kuo, Jen-Yuan, Yang, Ten-Fang, Wu, Yih-Jer, Lee, Ying-Hsiang
Publicado 2021